FINWIRES · TerminalLIVE
FINWIRES

RBCによると、ドミノ・ピザは株価評価の低下にもかかわらず、不利な状況に直面している。

-- RBCキャピタル・マーケッツは水曜日のレポートで、ドミノ・ピザ(DPZ)の第1四半期の売上高と利益は「市場予想をやや下回る」可能性が高いと述べた。 RBCによると、同社は「株価が低迷しているにもかかわらず、業績予想の下方修正の可能性」があるため、リスク・リターンは「やや不利」であるとレポートは指摘している。 RBCは、マクロ経済の圧力が高まる可能性から、第1四半期に競合他社の店舗閉鎖による恩恵を受ける可能性があるにもかかわらず、同社経営陣は2026年の国内既存店売上高成長率のガイダンスを3%から若干下方修正する可能性があると述べている。 投資会社RBCによると、ヤム・ブランズ(YUM)傘下のピザハットとパパ・ジョンズ(PZZA)は、今年合わせて約500店舗を閉鎖する予定で、その大半は第1四半期に閉鎖される見込みだという。 RBCはまた、ドミノ・ピザの第1四半期の米国既存店売上高成長率を2.7%と予想しており、これは市場コンセンサス予想の3.0%増を下回る水準です。 一方、RBCは、原油価格の高騰が消費支出に影響を与える可能性があるものの、同社の海外既存店売上高成長率は市場予想とほぼ同水準になると見ています。RBCは、同社の中東における直接的な事業展開は、システム売上高のわずか一桁台前半に過ぎないと指摘しています。 RBCはドミノ・ピザの投資判断を「セクター・パフォーム」とし、目標株価を425ドルから400ドルに引き下げました。

Price: $368.12, Change: $-1.05, Percent Change: -0.29%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB